The West Australian reports that the State Government is expanding its FluMist program, which delivers a needle-free influenza vaccine via nasal spray. After an earlier rollout for younger children, the program is now being extended to cover children and teenagers aged 12 to 17. The expansion makes FluMist available to this age group without cost. The reporting also links the change to efforts to improve flu vaccination coverage, with current vaccination rates described as falling short of official targets. By widening eligibility, the program aims to increase uptake among older children and reduce the number of people not protected during flu season. Overall, the expansion builds on the initial implementation of FluMist and reflects a broader push to close the gap between current vaccination performance and set targets, while maintaining the needle-free option for eligible recipients.